Zebrafish Aspergillus Infection Models

Introduction

Aspergillosis is a group of fungal diseases caused by Aspergillus species, with Aspergillus fumigatus being the predominant cause of invasive disease. Clinical manifestations range from allergic and chronic pulmonary disease to invasive pulmonary aspergillosis and disseminated infection. Invasive aspergillosis occurs mainly in immunocompromised individuals, including patients with hematological malignancies, hematopoietic stem-cell or solid-organ transplantation, prolonged corticosteroid exposure, and other conditions associated with impaired host immunity. Pulmonary infection may present with fever, cough, chest pain, dyspnea, and progressive respiratory failure, while dissemination can involve the brain and other organs.

Current treatment relies mainly on triazole antifungals such as voriconazole and isavuconazole, with liposomal amphotericin B used as an alternative in selected cases. However, diagnosis can be difficult, and antifungal resistance, host immunosuppression, and variable treatment responses remain important challenges. Zebrafish provide a complementary in vivo system for investigating Aspergillus-host interactions, particularly innate immune responses, fungal germination, hyphal development, and therapeutic activity. Their optical transparency and genetic accessibility enable longitudinal visualization of infection in living larvae and support mechanistic studies and early-stage antifungal screening.

Why Zebrafish?

• Real-Time Infection Imaging: Transparent larvae enable direct visualization of fungal growth and immune-cell interactions.
• Innate Immunity: Early larvae provide a practical system for studying macrophage- and neutrophil-mediated defense.
• Genetic Tractability: Immune-deficient and reporter lines facilitate mechanism-focused studies.
• Screening Compatibility: Small size and rapid development support compound efficacy studies with limited test material.

Available Zebrafish Disease Models

The following models represent the most established configurations suitable for research and CRO-based study design:

Phenotypic Evaluation

Key Applications

• Antifungal Drug Screening: Evaluate the in vivo efficacy of antifungal compounds against A. fumigatus infection.
• Host–Pathogen Interaction Studies: Investigate interactions between fungal conidia, hyphae, macrophages, and neutrophils in a living vertebrate host.
• Fungal Virulence Studies: Compare wild-type and genetically modified Aspergillus strains to identify factors associated with fungal persistence and pathogenicity.
• Host Susceptibility Studies: Examine how impaired macrophage or neutrophil function affects fungal clearance and disease progression.
• Mechanism-of-Action Studies: Characterize how candidate antifungal or host-directed therapies influence fungal growth, immune-cell recruitment, and infection outcomes.

Study Examples

Distinct macrophage and neutrophil responses to A. fumigatus. Larval zebrafish were infected with fluorescently labeled A. fumigatus conidia and monitored using immune-cell reporter lines and live imaging. Macrophages rapidly phagocytosed conidia and formed aggregates around developing hyphae, whereas neutrophil recruitment was associated mainly with hyphal growth. Depletion or functional impairment of macrophages or neutrophils increased susceptibility to invasive disease under specific experimental conditions.

Fig. 1. Macrophages preferentially respond to fungal conidia, whereas neutrophils are recruited during hyphal development (Knox BP, et al., 2014).

Zebrafish model for evaluating host-directed antifungal activity. An established larval zebrafish A. fumigatus infection model was used to evaluate whether bifunctional compounds could enhance neutrophil-mediated fungal clearance. Because macrophages normally dominate early conidial phagocytosis, macrophage-reduced larvae were used to better assess neutrophil activity. Candidate compounds were evaluated in vivo by monitoring neutrophil interaction with fungal conidia and subsequent fungal clearance. Treatment increased neutrophil-associated phagocytosis in the engineered immune-cell setting, supporting the use of zebrafish as an in vivo platform for evaluating host-directed antifungal approaches alongside conventional pathogen-targeted therapies.

Fig. 2. Bifunctional compounds enhance neutrophil-mediated recognition and clearance of A. fumigatus (O'Brien et al., 2019).

References

1. Knox BP, et al. Distinct Innate Immune Phagocyte Responses to Aspergillus fumigatus Conidia and Hyphae in Zebrafish Larvae. Eukaryotic Cell 13(10), 1266–1277 (2014).
2. O'Brien et al. Bifunctional Small Molecules Enhance Neutrophil Activities Against Aspergillus fumigatus in vivo and in vitro. Frontiers in Immunology 10, 644 (2019).